Literature DB >> 12437957

Enzymatic degradation behavior and mechanism of poly(lactide-co-glycolide) foams by trypsin.

Qing Cai1, Guixin Shi, Jianzhong Bei, Shenguo Wang.   

Abstract

The purpose of this study is to investigate the enzymatic degradation behaviors of porous poly(lactide-co-glycolide) (PLGA) foams in the presence of trypsin, in comparison with their hydrolytic degradation. To inspect the effect of trypsin on the degradation of PLGA, both the hydrolytic and enzymatic degradation of non-porous PLGA samples were also performed. The changes of molecular weight and molecular weight distribution (polydispersity) during the degradation were determined by gel permeation chromatograph. And the changes of weight, thickness and morphology with the degradation were also measured. The degradation of PLGA displayed as two stages. In the first stage, the molecular weight of PLGA decreased continuously with degradation time, whereas little weight loss occurred. But in the second stage, the molecular weight of PLGA had decreased to a low value and was almost unchanged with time, while the sample experienced significant weight loss. And it was found that the presence of trypsin could significantly accelerate the weight loss rates of all the PLGA samples, but it caused little difference in the decrease of molecular weight and the change of PLGA composition between the enzymatic and hydrolytic degradation. Therefore, the enzymatic degradation of PLGA was still primarily a hydrolysis process. A mechanism of enzymatic degradation was proposed that the trypsin could enhance the weight loss of PLGA by acting as surfactant to push the dispersion of degradation products into water even though they could not dissolve in water.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12437957     DOI: 10.1016/s0142-9612(02)00377-0

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  24 in total

1.  Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease.

Authors:  Eiji Saito; Robert Kuo; Kevin R Kramer; Nishant Gohel; David A Giles; Bethany B Moore; Stephen D Miller; Lonnie D Shea
Journal:  Biomaterials       Date:  2019-08-17       Impact factor: 12.479

2.  Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.

Authors:  Nattawut Leelakanok; Sean M Geary; Aliasger K Salem
Journal:  J Pharm Sci       Date:  2017-10-12       Impact factor: 3.534

Review 3.  IL-1Ra and its delivery strategies: inserting the association in perspective.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Shuqing Chen
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

4.  Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.

Authors:  Kaori Kimishima; Tomonori Matsuno; Jun Makiishi; Gaku Tamazawa; Yu Sogo; Atsuo Ito; Tazuko Satoh
Journal:  Odontology       Date:  2014-12-23       Impact factor: 2.634

5.  Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy.

Authors:  S Hariharan; V Bhardwaj; I Bala; J Sitterberg; U Bakowsky; M N V Ravi Kumar
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

6.  Growth and electrophysiological properties of rat embryonic cardiomyocytes on hydroxyl- and carboxyl-modified surfaces.

Authors:  Anupama Natarajan; Changju Chun; James J Hickman; Peter Molnar
Journal:  J Biomater Sci Polym Ed       Date:  2008       Impact factor: 3.517

7.  Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.

Authors:  Vanna Sanna; Imtiaz Ahmad Siddiqui; Mario Sechi; Hasan Mukhtar
Journal:  Mol Pharm       Date:  2013-09-04       Impact factor: 4.939

8.  Body distribution of poly(D,L-lactide-co-glycolide) copolymer degradation products in rats.

Authors:  Nan Hua; Jiao Sun
Journal:  J Mater Sci Mater Med       Date:  2008-05-13       Impact factor: 3.896

9.  Pre-clinical evaluation of a themosensitive gel containing epothilone B and mTOR/Hsp90 targeted agents in an ovarian tumor model.

Authors:  Dae Hwan Shin; Glen S Kwon
Journal:  J Control Release       Date:  2017-10-19       Impact factor: 9.776

Review 10.  Delivery of therapeutic proteins.

Authors:  Dipak S Pisal; Matthew P Kosloski; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.